Arcutis Biotherapeutics (ARQT) Stock Price, Quote, News & History

Q: What sector and industry does Arcutis Biotherapeutics (ARQT) operate in?

Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Arcutis Biotherapeutics (ARQT) Stock Price, Quote, News & History

ARQTNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$25.37

-0.36-1.40%

At close: Jan 30, 4:00 PM EST

$25.60

0.230.91%

After Hours: Jan 30, 4:23 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$25.37

Close

$25.37

Volume / Avg.

929.21K / 2.12M

Day Range

$24.96 - $25.63

52 Wk Range

11.13 - 31.77

Market Cap

$3.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

15.06%

Days to Cover

7.86

Recent Arcutis Biotherapeutics Inc News

Crude Oil Falls Over 2%; PayPal Shares Spike Higher

Avi Kapoor

Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Top 5 Biotech Stocks With Strong Momentum

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-32.56M

Investing Cash Flow (TTM)

38.80M

Financing Cash Flow (TTM)

-94.16M

Free Cash Flow (TTM)

-48.24M

Capital Expenditure (TTM)

-15.69M

Net Change in Cash (TTM)

-87.92M

Analyst Trends and Forecast

1

Aug 25

1

Oct 25

1

Nov 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.03B

PE Ratio (TTM)

-

PE Ratio (FWD)

59.88

PEG Ratio (TTM)

-

PS Ratio (TTM)

10.22

PB Ratio (TTM)

19.93

Earnings Yield % (TTM)

-1.34%

Earnings Yield % (FWD)

1.67%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.29

Company Debt

Total Debt

$108.50M

LT Debt

$107.50M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$47.12M

Debt to Equity

0.72

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$25.37

Close

$25.37

Volume / Avg.

929.21K / 2.12M

Day Range

$24.96 - $25.63

52 Wk Range

11.13 - 31.77

Market Cap

$3.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

15.06%

Days to Cover

7.86

About

Sector

Health Care

Industry

Biotechnology

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentia...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Arcutis Biotherapeutics (ARQT) stock?

A

You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arcutis Biotherapeutics (ARQT) competitors?

A

Other companies in Arcutis Biotherapeutics’s space includes: Immunome Inc (NASDAQ:IMNM), IDEAYA Biosciences Inc (NASDAQ:IDYA), Twist Bioscience Corp (NASDAQ:TWST), Legend Biotech Corp (NASDAQ:LEGN) and Centessa Pharmaceuticals PLC (NASDAQ:CNTA).

Q

What is the forecast, or price target, for Arcutis Biotherapeutics (ARQT) stock?

A

Arcutis Biotherapeutics has a consensus price target of $28.00.

Q

What is the current price for Arcutis Biotherapeutics (ARQT)?

A

The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $25.6 last updated January 30, 2026 at 4:23 PM EST.

Q

Does Arcutis Biotherapeutics (ARQT) pay a dividend?

A

There are no upcoming dividends for Arcutis Biotherapeutics.

Q

When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?

A

Arcutis Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Arcutis Biotherapeutics (ARQT) going to split?

A

There is no upcoming split for Arcutis Biotherapeutics.

Q

What sector and industry does Arcutis Biotherapeutics (ARQT) operate in?

A

Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

IDEAYA Biosciences Inc

NASDAQ:IDYA

$32.19

%

Twist Bioscience Corp

Centessa Pharmaceuticals PLC

NASDAQ:CNTA

$24.65

0.33%

Xenon Pharmaceuticals Inc

NASDAQ:XENE

$41.01

%

Viking Therapeutics Inc

NASDAQ:VKTX

$29.20

0.55%

Kiniksa Pharmaceuticals International PLC

NASDAQ:KNSA

$43.92

%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$25.37

Close

$25.37

Volume / Avg.

929.21K / 2.12M

Day Range

$24.96 - $25.63

52 Wk Range

11.13 - 31.77

Market Cap

$3.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

15.06%

Days to Cover

7.86

Recent Arcutis Biotherapeutics Inc News

Crude Oil Falls Over 2%; PayPal Shares Spike Higher

Avi Kapoor

Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Top 5 Biotech Stocks With Strong Momentum

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-32.56M

Investing Cash Flow (TTM)

38.80M

Financing Cash Flow (TTM)

-94.16M

Free Cash Flow (TTM)

-48.24M

Capital Expenditure (TTM)

-15.69M

Net Change in Cash (TTM)

-87.92M

Analyst Trends and Forecast

1

Aug 25

1

Oct 25

1

Nov 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.03B

PE Ratio (TTM)

-

PE Ratio (FWD)

59.88

PEG Ratio (TTM)

-

PS Ratio (TTM)

10.22

PB Ratio (TTM)

19.93

Earnings Yield % (TTM)

-1.34%

Earnings Yield % (FWD)

1.67%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.29

Company Debt

Total Debt

$108.50M

LT Debt

$107.50M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$47.12M

Debt to Equity

0.72

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$25.37

Close

$25.37

Volume / Avg.

929.21K / 2.12M

Day Range

$24.96 - $25.63

52 Wk Range

11.13 - 31.77

Market Cap

$3.14B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

15.06%

Days to Cover

7.86

About

Sector

Health Care

Industry

Biotechnology

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentia...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry